Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-12-03
DOI
10.1038/s41409-020-01163-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How I treat measurable (minimal) residual disease in acute leukemia after allogeneic hematopoietic cell transplantation
- (2020) Alexandros Spyridonidis BLOOD
- Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century
- (2020) Masamitsu Yanada et al. ANNALS OF HEMATOLOGY
- Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation (SORMAIN)
- (2020) Andreas Burchert et al. JOURNAL OF CLINICAL ONCOLOGY
- Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation
- (2019) Li Xuan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
- (2019) Thierry Guillaume et al. BONE MARROW TRANSPLANTATION
- CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes
- (2018) Marcos de Lima et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Acute myeloid leukaemia relapsing after allogeneic haemopoietic stem cell transplantation: prognostic factors and impact of initial therapy of relapse
- (2018) Andrew B. M. Lim et al. INTERNAL MEDICINE JOURNAL
- Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
- (2018) Mohamed A. Kharfan-Dabaja et al. JAMA Oncology
- Mechanisms of immune escape after allogeneic hematopoietic cell transplantation
- (2018) Robert Zeiser et al. BLOOD
- Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
- (2018) Christoph Schmid et al. BRITISH JOURNAL OF HAEMATOLOGY
- HLA discrepancy between graft and host rather than that graft and first donor impact the second transplant outcome
- (2018) Yoshinobu Maeda et al. HAEMATOLOGICA
- Measurable residual disease-guided treatment with azacitidine to prevent haematological relapse in patients with myelodysplastic syndrome and acute myeloid leukaemia (RELAZA2): an open-label, multicentre, phase 2 trial
- (2018) Uwe Platzbecker et al. LANCET ONCOLOGY
- Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
- (2017) S.K. Metzelder et al. EUROPEAN JOURNAL OF CANCER
- Effect of cytogenetic risk status on outcomes for patients with acute myeloid leukemia undergoing various types of allogeneic hematopoietic cell transplantation: an analysis of 7812 patients
- (2017) Masamitsu Yanada et al. LEUKEMIA & LYMPHOMA
- Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT
- (2016) P Tsirigotis et al. BONE MARROW TRANSPLANTATION
- Haematopoietic cell transplantation with and without sorafenib maintenance for patients withFLT3-ITD acute myeloid leukaemia in first complete remission
- (2016) Andrew M. Brunner et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia
- (2016) C. Craddock et al. HAEMATOLOGICA
- Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia
- (2016) C. Craddock et al. HAEMATOLOGICA
- Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study
- (2015) Nelli Bejanyan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- (2015) Iskra Pusic et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)
- (2015) Yoshiko Atsuta INTERNATIONAL JOURNAL OF HEMATOLOGY
- Donor Lymphocyte Infusion for the Treatment of Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
- (2014) Akiyoshi Takami et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Second Allograft for Hematologic Relapse of Acute Leukemia After First Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors: The Role of Donor Change
- (2013) Maximilian Christopeit et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
- (2011) C. Schmid et al. BLOOD
- Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial
- (2011) U Platzbecker et al. LEUKEMIA
- Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A
- (2010) Richard F. Schlenk et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now